# Lopinavir/Ritonavir (Kaletra) PK in Children

> **NCT00810108** · PHASE4 · COMPLETED · sponsor: **Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)** · enrollment: 12 (actual)

## Conditions studied

- HIV/AIDS Treatment
- HIV Infections

## Interventions

- **DRUG:** lopinavir/ritonavir (Kaletra®) tablets

## Key facts

- **NCT ID:** NCT00810108
- **Lead sponsor:** Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00810108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00810108, "Lopinavir/Ritonavir (Kaletra) PK in Children". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00810108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*